Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Marken announced today that it has been granted approval for a customs-bonded warehouse within the Marken depot in Frankfurt, Germany. This will allow Marken to store pharmaceuticals with an origin outside the European Union (EU) and distribute them ...
read more
Targos GmbH, a leader in clinical biomarker services, and WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced a strategic ...
read more
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that its manufacturing subsidiary, Syn-The-All Pharmaceutical ...
read more
Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), and Sigma-Aldrich Corporation (NASDAQ: SIAL) announced today an exclusive manufacturing license and supply agreement that will allow Sigma-Aldrich to manufacture...
read more
Cenix BioScience GmbH (Cenix), a leading preclinical contract research provider and technology developer specialized in RNAi- based genomics and high content screening-driven pharmacology, today announced that is has signed a research service ...
read more
AbbVie (NYSE: ABBV) has named Michael Severino, M.D. its new Executive Vice President, Research and Development (R&D) and Chief Scientific Officer. Dr. Severino's track record of innovation within the biotech industry aligns with AbbVie's vision as ...
read more
Craigavon-based pharmaceutical development company Almac recorded pre-tax profits of £19.2m in 2013, up around 30% on the previous year, it has announced.
read more
Since 2000, PharmaCore has performed a variety of chemistry services for leading pharmaceutical and biotechnology companies including: custom organic synthesis; cGMP scale-up; nonGMP and GMP API manufacture; ; chemical process research and ...
read more
Indian pharmacovigilance consulting and drug safety services company Oviya MedSafe Pvt Ltd has
signed an agreement with British software development company Assured Information Systems Ltd to
combine the former's drug safety services with the ...
read more
CRF Health is hosting the 2014 eCOA Forum Scientific Sessions, a unique event taking place June 24-25, 2014 at the University of Oxford. As a collaboration of CRF Health, Mapi and Isis Outcomes, this meeting brings together world leaders in PRO ...
read more
IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced that it has received tentative approval from the U.S. Food & Drug Administration (FDA) for its abbreviated new drug application (ANDA) ...
read more
Crown Bioscience, Inc., a leading global drug discovery and development service company, today announced its HuPrime® PDX (Patient-Derived Xenograft) model collection has now passed the 1,000 individual models mark.
read more
(BUSINESS WIRE) – Ash Stevens, Inc., a leading provider of global contract pharmaceutical drug substance development and active pharmaceutical ingredient (API) manufacturing services, is pleased to announce receipt of a 2014 Lilly Global Supplier ...
read more
Capsugel today announced an agreement with Chiasma, Inc., wherein Capsugel’s Dosage Form Solutions (DFS) business unit is scaling up manufacturing for the only investigational oral form of octreotide in clinical development. The drug candidate is in ...
read more
Cytovance Biologics, Inc., a leading full-service contract manufacturer (“CMO”) of mammalian and microbial biologics, announces a development and manufacturing agreement with Selexys Pharmaceuticals, Corp., an Oklahoma City-based clinical stage ...
read more